Navigation Links
SYNTAX Analysis Finds Treatment With TAXUS(R) Express2(TM) Stents More Cost Effective Than Bypass Surgery in Many Patients With Complex Coronary Artery Disease
Date:3/28/2009

usiness decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements. This cautionary statement is applicable to all forward-looking statements contained in this document.

    CONTACT:  Paul Donovan
              508-650-8541 (office)
              508-667-5165 (mobile)
              Media Relations
              Boston Scientific Corporation

              Larry Neumann
              508-650-8696 (office)
              Investor Relations
              Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
2. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
3. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
4. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
5. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
6. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
7. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
8. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
9. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
10. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
11. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... MARLBOROUGH, Mass. , Aug. 30, 2014 /PRNewswire/ ... from its NEural Cardiac TherApy foR Heart Failure ... sham-controlled clinical trial investigating vagus nerve stimulation (VNS) ... Zannad, M.D., Ph.D., Professor of Therapeutics and Cardiology ... the Institut National de la Sante et de ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... -- Market Research Report on Global and Chinese ... and in-depth market survey on Global and ... firstly reviews the basic information of X-Ray Crystallography ... The report then explores global and China,s top ... specification, capacity, Production value, and market share etc. ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... 8, 2011 K-V Pharmaceutical Company (NYSE: KV.A/ KV.B) (the ... ® , the only U.S. Food & Drug Administration ("FDA") ... in women with singleton pregnancy who have a history of ... was launched during March of 2011. From its launch date ...
... 8, 2011 Thompson MIS is pleased to announce ... "Best New Technology for Spine Care in 2011" award ... the company during the annual meeting of the North ... is a patented system that enables surgeons to more ...
Cached Medicine Technology:K-V Pharmaceutical Announces Updated Makena® Performance Metrics 2K-V Pharmaceutical Announces Updated Makena® Performance Metrics 3K-V Pharmaceutical Announces Updated Makena® Performance Metrics 4K-V Pharmaceutical Announces Updated Makena® Performance Metrics 5K-V Pharmaceutical Announces Updated Makena® Performance Metrics 6K-V Pharmaceutical Announces Updated Makena® Performance Metrics 7K-V Pharmaceutical Announces Updated Makena® Performance Metrics 8
(Date:8/30/2014)... Fast hosting is a great choice for webmasters ... professional web hosting suppliers and announces that Bluehost, ... suppliers of fastest web hosting in 2014. , ... hosting supplier. Actually, these companies have outperformed their ... customer support. People can get the best web ...
(Date:8/30/2014)... 30, 2014 According to Bloomberg ... that requires Takeda Pharmaceutical Co. and Eli Lilly & ... claims that the drugmakers concealed information about a risk ... The case, Allen v. Takeda Pharmaceuticals North America Inc. ... District of Louisiana (Lafayette).* , According to Bloomberg, Takeda ...
(Date:8/30/2014)... Recently, Skmen.com, a well-known clothing manufacturer, has announced ... Before the middle of September, all the company’s new ... 15 to 30 percent off. , As a ... are carefully made and come with quality guarantees. They ... Skmen.com is popular for its fashionable, high quality clothes ...
(Date:8/30/2014)... Ticket Down reports that ticket demand is high for ... Levi's Stadium. The summer months of 2014 have been ... due to the fact that so many international teams have participated ... of these games were practice games in preparation for the 2014 ... is a brand new facility that will be the home field ...
(Date:8/30/2014)... Midland, TX (PRWEB) August 30, 2014 ... Quotes Pros company to introduce better prices to consumers ... insurance plans can be found when using the open ... The national lookup system available to use this year ... for insurance based on general location and not from ...
Breaking Medicine News(10 mins):Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... CHICAGO Results of a 10-year study published in the ... Medicine found that magnesium sulfate administered to women delivering ... palsy by 50 percent. The Beneficial Effects of Antenatal Magnesium ... U.S., including Northwestern Memorial, and is the first prenatal intervention ...
... explains financial implications of SSDI benefits, online financial planning calculators available ... ... August 29, 2008 -- Deciding how to move forward after a ... important that individuals do as much as they can to understand ...
... daytime tiredness, symptoms of depression , , THURSDAY, Aug. 28 ... provide direct care during the night for someone with ... U.S. researchers say. , The study compared 31 ... slept about 33 minutes less per night than non-caregivers ...
... VIEW, Calif., Aug. 28 The 2008 European,Hemodialysis Emerging ... in recognition of its pioneering Redsense -- a unique ... during hemodialysis,and may save the lives of many patients"., ... sensor patch. The sensor is,connected to the alarm using ...
... the Northeast region with more hires,planned throughout the ... Aug. 28 The Pennsylvania,Patient Safety Authority has ... to help healthcare facilities that report to the,Pennsylvania ... Pennsylvania citizens., "Last year in focus groups ...
... FDA lifts advisory against eating raw Mexican jalapeno and ... -- U.S. health officials declared Thursday that the nationwide ... against eating raw jalapeno and serrano peppers grown in ... available information and reports, it appears that this outbreak ...
Cached Medicine News:Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3Health News:Salmonella Outbreak Over, U.S. Says 2Health News:Salmonella Outbreak Over, U.S. Says 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: